TP53 and colorectal carcinoma: Additionally, we provided the first evidence of CTCF involvement in the P53-Hedgehog signaling pathway and confirmed the effects of aberrant CTCF expression on the cellular biological behavior, including proliferation and chemotherapy resistance to 5-fluorouracil (5-FU), of CRC cells in vitro as well as on tumor growth in vivo.